Medscape Medical NewsAll articles

SIGNA Champion

GE Healthcare (Tianjin) Company Limited • Radiology • 01/19/2024

510(k)IEC 62304 Class B§524B Cyber Device
FDA Summary PDF

Device Purpose

The SIGNATM Champion is a 1.5T whole-body magnetic resonance scanner engineered for comprehensive diagnostic imaging, providing high-resolution images, high signal-to-noise ratios, and reduced scan times through its advanced hardware components and deep learning-based software like Sonic DL and AIR Recon DL. Its methodology relies on detecting magnetic resonance signals from nuclei within the body using time-varying magnetic fields and RF pulses to generate a wide array of image types, including spectroscopic and dynamic studies, to aid physicians in diagnosis.

Summary

The SIGNATM Champion is a 1.5 Tesla whole-body magnetic resonance (MR) scanner designed to produce high-resolution diagnostic images with high signal-to-noise ratios and short scan times. It is indicated for use in imaging the entire body—including head, neck, spine, heart, abdomen, pelvis, joints, and musculoskeletal regions—producing axial, sagittal, coronal, oblique images, as well as spectroscopic images, parametric maps, spectra, and dynamic images of anatomical structures and functions. The system utilizes time-varying magnetic fields and radiofrequency (RF) transmissions to capture information about the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance, and can be used with contrast agents depending on the imaging needs. The SIGNATM Champion incorporates several hardware modifications compared to its predicate (SIGNATM Voyager), including a new magnet enclosure, patient table, host computer, RF transmit chain (featuring an In Scan Room architecture from a reference device), and wireless gating capabilities. It also introduces advanced software features such as Sonic DL and AIR Recon DL, similar to those in a reference device (SIGNATM Hero), which are deep learning-based reconstruction algorithms. While employing the same fundamental scientific MR technology as its predicate, these enhancements aim to improve performance and user experience. Bench testing and sample clinical images were used to demonstrate acceptable diagnostic image quality, comparable to the predicate device.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Magnetic Resonance ScannerWhole Body Imaging1.5T MagnetHigh Resolution ImagingShort Scan TimesDiagnostic Imaging DeviceSpectroscopic ImagingSonic DLAIR Recon DLWireless Gating

Device Metadata

Submission Number
K233728
Company
GE Healthcare (Tianjin) Company Limited
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How do Sonic DL and AIR Recon DL quantitatively impact specific image quality metrics (e.g., SNR, CNR, spatial resolution, artifact reduction) and scan time efficiency across different anatomical regions and pulse sequences compared to conventional reconstruction techniques on GE systems?; What are the measurable benefits of the redesigned patient table and magnet enclosure in terms of patient comfort, throughput, or accessibility for diverse patient populations (e.g., bariatric, claustrophobic)?; For which specific clinical applications or challenging imaging scenarios (e.g., motion-prone patients, complex anatomies) do the new hardware and software features of SIGNATM Champion offer the most significant diagnostic advantages over the SIGNATM Voyager?; What specific bench testing methodologies and phantom studies were conducted to validate the performance of the modified RF transmit chain and the wireless gating system, particularly concerning signal integrity and SAR management?; Can GE Healthcare provide comparative image sets from the SIGNATM Champion and the predicate SIGNATM Voyager, acquired under identical conditions for specific clinical indications, to allow for an independent assessment of the claimed substantial equivalence in diagnostic image quality?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score20/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(wireless)
✓ Detected
HBOMHardware Bill of Materials(hardware)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
SIGNA Champion - GE Healthcare (Tianjin) Company Limited | ESL FDA AI Device Intelligence